Striving for 2020 – Optimizing Outcomes in Medical Retina

My Session Status

Kiedy:

13:30, sobota 27 cze 2020 (1 godz. 30 min.)

Gdzie:

Vancouver Convention Centre (East Building) - Ballroom B

Ścieżka:

Retina

LEARNING OBJECTIVES:

To integrate up-to-date and evidence-based treatment strategies in the clinical management of neovascular age-related macular degeneration.
To apply best-practice guidelines in the management of patients with pentosan maculopathy.
To determine how the presence of macular fluid influences visual outcomes in eyes with neovascular age-related macular degeneration.

CANMEDS ROLES: Medical Expert, Scholar

Elementy podrzędne

The Muller Cell Cone and its Importance in Macular Disease

13:30 - 13:50 | 20 min.

Retina

David Sarraf, MD

Keynote speaker

Efficacy of Intravitreal Aflibercept Administered Using a Treat-and-Extend Regimen Over 2 Years in Patients with Neovascular Age-Related Macular Degeneration: The ARIES Study Results

13:50 - 14:00 | 10 min.

Retina

Varun Chaudhary

Speaker

14:00 - 14:05 | 5 min.

Retina

Canadian Treat-and-Extend Trial with Ranibizumab in nAMD Patients: CANTREAT 36-month Extension Results

14:05 - 14:15 | 10 min.

Retina

Peter Kertes

Speaker

14:15 - 14:20 | 5 min.

Retina

Geographic Atrophy in the Canadian Treat and Extent Trial with Ranibizumab in patients with nAMD

14:20 - 14:30 | 10 min.

Parnian Arjmand MD

Speaker

14:30 - 14:35 | 5 min.

Retina

Re-Thinking Fluid in the Treatment of nAMD

14:35 - 15:00 | 25 min.

Retina

Nancy Holekamp, MD

Keynote speaker

My Session Status

Send Feedback